U.S. IPO Week Ahead: A Biotech Wave Drives 7 IPOs While Slack Targets A Direct Listing
U.S. IPO Week Ahead: A Biotech Wave Drives 7 IPOs While Slack Targets A Direct Listing.....»»
The Week Ahead In Biotech: Johnson & Johnson, Biogen Earnings, Neurology Conference And IPOs
Biotech stocks reversed course in the week ended April 16, with the sector re.....»»
8 expert predictions ahead of Coinbase"s hotly anticipated IPO next week
Insider compiled views from eight experts on what they see for the cryptocurrency exchange ahead of its eagerly-awaited public listing next week. Reuters Coinbase is set to go public via direct listing on Apri.....»»
The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs and Conference Presentations In The Spotlight
Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vaccine updates, M&A activity, IPO news flow and follow-on offerings all served to lift stocks higher. read more.....»»
The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs and Conference Presentations In The Spotlight
Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vac.....»»
The Week Ahead In Biotech: 2 IPOs Plus FDA Decisions On Moderna"s COVID Vaccine And Drugs From Amgen, MacroGenics
Biotech stocks advanced for a third straight week, defying the broader market weakness. The space got solid support from positive stock reactions to presentations made at hematology and breast cancer conferences. read more.....»»
Exclusive: Tencent-backed WeDoctor invites banks to lead $1 billion Hong Kong IPO, sources say
WeDoctor will push ahead with a Hong Kong listing and invite pitches from investments banks next week to lead an IPO valuing the Chinese healthcare platform at up to $10 billion, two sources with direct knowledge of the matter said......»»
The Week Ahead In Biotech: Pfenex And Clinuvel On The Radar Ahead of FDA Decisions, 2 IPOs On Deck
Notwithstanding the ESMO conference generating some huge moves in some stocks, last week turned out to be a muted one for biotechs. read more.....»»
The Week Ahead In Biotech (Sept. 29-Oct. 5): Conference Presentations, IPOs Hit Top Gear
Biotech stocks came under selling pressure in the week ended Sept. 27 amid clinical data readouts and a handful of FDA decisions. read more.....»»
The Week Ahead In Biotech: Novo Nordisk And Merck Await FDA Rulings, 2 IPOs On Deck
Biotech stocks rebounded in last week after declining modestly in the previous week. read more.....»»
U.S. IPO Week Ahead: Summer"s Last Wave With 5 IPOs
U.S. IPO Week Ahead: Summer"s Last Wave With 5 IPOs.....»»
Slack Is Going Public Without an IPO. Here’s How a Direct Listing Works
Direct offerings feature less trading volatility than IPOs. Ten years a.....»»
Slack listing comes during banner year for tech IPOs despite Uber and Lyft’s troubled debuts
What has so far been a banner year for tech initial public offerings is expected to receive a substantial jolt Thursday when messaging platform Slack Technologies Inc. debuts in a direct listing......»»
4 Things Investors Need to Know About Slack’s Direct Listing
“Two is a trend, but it’s not a terribly meaningful trend,†says one analyst of direct listings. Slack is finally going public this week--but don’t expe.....»»
Slack targets June 20 for direct listing, Reuters says
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Biotech stocks staged a recovery this week after being in the red in the previous two weeks. read more.....»»
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Biotech stocks staged a recovery this week after being in the red in the previous two weeks. AbbVie Inc (NYSE: ABBV)'s psoriasis drug Skyrizi received FDA nod. The week also saw the release of strong quarterly earnings by big European pharma gian.....»»
The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs
Biotech stocks are on track to extend their losses, bucking the positive broader market sentiment. The week saw Achaogen Inc (NASDAQ: AKAO) filing for Chapter 11 bankruptcy and negative clinical readouts .....»»
The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs
Biotech stocks witnessed a slowdown in momentum last week, which was a relatively slow one in terms of news flow. Amgen, Inc. read more.....»»
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs
Biotech stocks came under pressure last week despite two FDA approvals coming through. read more.....»»